Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 8.44Vijaya Diagnostic Centre Ltd. demonstrates robust financial health, anchored by exceptional profitability and impressive growth. The company consistently turns a large portion of its revenue into profit and is expanding its business at a remarkable rate. Its financial foundation is very stable, as it relies much more on its own funds than on debt, significantly reducing long-term risks. Day-to-day operations are a key strength, with the company managing its inventory and collecting payments from customers with outstanding speed. However, there are areas of contrasting performance. While daily operations are efficient, the company is not yet generating high levels of revenue from its large investments in buildings and equipment. Its ability to cover short-term bills, while currently adequate, shows a declining trend. The future outlook appears positive, driven by strong growth and profitability, though its use of assets to generate sales and management of short-term cash will be important to observe.
Health Score : 8.44Vijaya Diagnostic Centre Ltd. demonstrates robust financial health, anchored by exceptional profitability and impressive growth. The company consistently turns a large portion of its revenue into profit and is expanding its business at a remarkable rate. Its financial foundation is very stable, as it relies much more on its own funds than on debt, significantly reducing long-term risks. Day-to-day operations are a key strength, with the company managing its inventory and collecting payments from customers with outstanding speed. However, there are areas of contrasting performance. While daily operations are efficient, the company is not yet generating high levels of revenue from its large investments in buildings and equipment. Its ability to cover short-term bills, while currently adequate, shows a declining trend. The future outlook appears positive, driven by strong growth and profitability, though its use of assets to generate sales and management of short-term cash will be important to observe.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
86.50
Industry Median
32.53
Small Cap Median
32.53
P/E RATIO
89.17
P/B RATIO
16.12
Industry Median
3.84
Small Cap Median
3.84
P/S RATIO
18.07
Industry Median
3.46
Small Cap Median
3.46
Others
PEG RATIO
0.00
EV/EBITDA RATIO
42.11
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1499 as on Sep 1, 2026.
Growth Score : 10.00The company is experiencing a period of exceptional and broad-based growth. It is successfully expanding its revenue, profits, and asset base at a very high rate. This indicates strong market demand for its services and effective execution of its growth strategy. The robust growth in earnings for shareholders is particularly positive. This all-around strong performance suggests a very positive trajectory for the business and a bright future outlook.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 22.55 | -0.65 | 19.39 | 24.27 | 19.53 |
| Operating Profit Growth Rate | 22.89 | -10.78 | 21.43 | 23.53 | 23.44 |
| Earnings Per Share (EPS) Growth | -42.27 | -22.96 | 40.05 | 20.07 | 20.59 |
| Asset Growth Rate | 31.79 | 19.64 | 15.24 | 29.6 | 18.29 |
| Net Income Growth Rate | 30.59 | -23.42 | 41.18 | 20 | 20.14 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Vijaya Diagnostic Centre Ltd | 8.44 | 89.17 | Neutral | 337.00 | 17.33 | 173.00 |
| 2 | Metropolis Healthcare Ltd | 7.76 | 63.50 | Neutral | 401.00 | 7.58 | 191.00 |
| 3 | Indegene Ltd | 7.58 | 36.36 | Overvalued | 619.00 | 8.80 | 401.00 |
| 4 | Entero Healthcare Solutions Ltd | 6.94 | 68.27 | Neutral | 266.00 | 6.18 | 146.00 |
| 5 | KOVAI | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤13th May 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Vijaya Diagnostic Centre Ltd. is one of the largest and fastest-growing integrated diagnostic chains in South India, offering a comprehensive range of pathology and radiology testing services. It operates a wide network of diagnostic centers and collection points, serving individual patients, hospitals, and corporate clients with a focus on quality and accessibility.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Vijaya Diagnostic Centre Ltd's P/E ratio (TTM) is 86.50, compared to the industry median of 32.53 and large cap median of 32.53.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Vijaya Diagnostic Centre Ltd's P/B ratio is 16.12, compared to the industry median of 3.84 and large cap median of 3.84.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Vijaya Diagnostic Centre Ltd's P/S ratio is 18.07, compared to the industry median of 3.46 and large cap median of 3.46.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Vijaya Diagnostic Centre Ltd's PEG ratio is 2.80.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Vijaya Diagnostic Centre Ltd's EV/EBITDA ratio is 42.11.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Vijaya Diagnostic Centre Ltd's ROE is 18.08%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Vijaya Diagnostic Centre Ltd's ROA is 22.36%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Vijaya Diagnostic Centre Ltd's ROCE is 21%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Vijaya Diagnostic Centre Ltd's operating margin is 41.40%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Vijaya Diagnostic Centre Ltd's net margin is 21.25%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Vijaya Diagnostic Centre Ltd's current ratio is 1.37.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Vijaya Diagnostic Centre Ltd's debt-to-equity ratio is 0.45.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Vijaya Diagnostic Centre Ltd's interest coverage ratio is 8.06.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Vijaya Diagnostic Centre Ltd's DPS is ₹2.02.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Vijaya Diagnostic Centre Ltd's EPS is 20.59.
(Source line: "Ratios as of 05 Nov 2026, based on last traded price of ₹1499. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1981
Headquarters: Hyderabad, Telangana
Core Offerings: Pathology services, Radiology services, Cardiology services, Preventive Health Checkups, Home sample collection
Stock Listing: NSE (VIJAYA), BSE (543350)
Promoter: Dr. S. Surendranath Reddy
1981: Founded by Dr. S. Surendranath Reddy, establishing its first diagnostic center in Hyderabad. Over the years: Expanded its presence across Telangana and Andhra Pradesh, becoming a leading integrated diagnostic service provider in South India. 2021: Successfully completed its Initial Public Offering (IPO), listing on NSE and BSE. Present: Continues to grow its network of diagnostic centers and improve its service offerings.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Diagnostic Services | 100% | N/A (single segment) |
Pathology Services: Offers a comprehensive range of routine and specialized pathology tests including biochemistry, microbiology, hematology, immunology, histopathology, cytology, and genetics. Utilizes state-of-the-art automated equipment.
Radiology & Imaging Services: Provides advanced imaging modalities such as MRI, CT Scan, Ultrasound, X-ray, Mammography, DEXA scans, and other diagnostic imaging procedures. Equipped with modern technology for accurate and timely diagnosis.
Cardiology & Other Services: Includes ECG, Treadmill Test (TMT), Echocardiography, and other cardiology-related diagnostic tests. Also offers preventive health check-up packages tailored for various age groups and health concerns.
Home Sample Collection: Provides the convenience of sample collection from patients' homes, extending accessibility and ease of service delivery across its operational regions.
Dr. S. Surendranath Reddy (Chairman & Managing Director): Founder of Vijaya Diagnostic Centre, a highly experienced radiologist with over four decades of expertise in diagnostic services, guiding the company's strategic vision and expansion.
No major subsidiaries reported.
No major recent corporate actions on record.
The Vijaya Diagnostic Centre Ltd share price today is ₹1499 on NSE (VIJAYA), as of 05 Nov 2026.
As of 05 Nov 2026, Vijaya Diagnostic Centre Ltd share price is ₹1499, with previous close ₹1499. Today's range is ₹1499 to ₹1499. The 52-week range is ₹848 to ₹1593.60.
As of today, Vijaya Diagnostic Centre Ltd's market cap is ₹14,705.19 crore (Mid Cap).
Vijaya Diagnostic Centre Ltd's current P/E ratio is 86.50, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 58.
Vijaya Diagnostic Centre Ltd's current P/B ratio is 16.12.
Vijaya Diagnostic Centre Ltd's current dividend yield is 0.13%. Last dividend of ₹1.00 per share was declared on 10-Aug-2023.
Vijaya Diagnostic Centre Ltd's EPS (TTM) is ₹20.59.
Vijaya Diagnostic Centre Ltd. is one of the largest and fastest-growing integrated diagnostic chains in South India, offering a comprehensive range of pathology and radiology testing services. It operates a wide network of diagnostic centers and collection points, serving individual patients, hospitals, and corporate clients with a focus on quality and accessibility.
Vijaya Diagnostic Centre Ltd is promoted by Dr. S. Surendranath Reddy, holding 52.51% as of 05 Nov 2026.
Vijaya Diagnostic Centre Ltd is listed on NSE (VIJAYA) and BSE (543350). Its next quarterly results are expected on August 2024.
Adjusted Earnings Per Share (Adjusted EPS)